Growth Hormone Is Beneficial for Induction of Spermatogenesis in Adult Patients With Congenital Combined Pituitary Hormone Deficiency.

Front Endocrinol (Lausanne)

National Health Commission (NHC) Key Laboratory of Endocrinology, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Published: May 2022

AI Article Synopsis

  • Gonadotropins can successfully induce sperm production in men with congenital combined pituitary hormone deficiency (CCPHD), but the effect of adding recombinant human growth hormone (rhGH) has been less studied.
  • In a study involving 60 male patients, those treated with both rhGH and gonadotropins experienced a significantly higher rate of spermatogenesis (96.77%) and a faster onset of sperm production compared to those receiving gonadotropins alone (62.07%).
  • The findings suggest that rhGH not only improves sperm production but also increases testosterone levels, indicating that combining rhGH with gonadotropins could be a beneficial treatment strategy for CCPHD patients.

Article Abstract

Background: Gonadotropins are effective in inducing spermatogenesis in patients with congenital combined pituitary hormone deficiency (CCPHD). Data on recombinant human growth hormone(rhGH) adjuvant treatment to improve gonadotropin-induced spermatogenesis are limited.

Design And Setting: This retrospective study included 60 male patients with CCPHD on a relatively large case series in a single center from mainland China. Twenty-nine patients who received gonadotropin therapy alone were defined as the Gn group, while 31 patients treated with a combination of rhGH and gonadotropins were defined as GH/Gn group.

Results: Spermatogenesis rate was 96.77% (30/31) and 62.07% (18/29) in the GH/Gn and Gn group, respectively (P < 0.001). The time for initial sperm appearance in the GH/Gn group was shorter than in the Gn group (14 versus 23 months, P < 0.001). A higher level of serum testosterone was achieved in the GH/Gn group than in the Gn group (4.79 versus 3.38 ng/mL, P = 0.026). After adjustment for potential confounders, rhGH supplementation was an independent beneficial factor on spermatogenesis (HR = 2.294, 95% CI: 1.143-4.604, P = 0.019).

Conclusions: rhGH induces earlier spermatogenesis in patients with CCPHD, which encourages the co-treatment with rhGH and gonadotropins in CCPHD patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074387PMC
http://dx.doi.org/10.3389/fendo.2022.868047DOI Listing

Publication Analysis

Top Keywords

gh/gn group
12
patients congenital
8
congenital combined
8
combined pituitary
8
pituitary hormone
8
hormone deficiency
8
spermatogenesis patients
8
patients ccphd
8
rhgh gonadotropins
8
patients
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!